SDF-1 inhibition targets the bone marrow niche for cancer therapy.

Roccaro, Am; Sacco, A; Purschke, Wg; Moschetta, M; Buchner, K; Maasch, C; Zboralski, D; Zöllner, S; Vonhoff, S; Mishima, Y; Maiso, P; Reagan, Mr; Lonardi, Silvia; Ungari, M; Facchetti, Fabio; Eulberg, D; Kruschinski, ; Vater, A; Rossi, G; Klussmann, S; Ghobrial, I. M.